Inactive Instrument

Esperite N.V. Stock price

Equities

ESP

NL0009272137

Healthcare Facilities & Services

Dynamic Chart
Esperite N.V. announced that it expects to receive €35 million in funding CI
Esperite N.V. and Myrisoph Capital Conclude a Strategic Agreement on Cryo-Save’s Family Stem Cell Banking Business CI
Esperite N.V. Reports Earnings Results for the Half Year Ended June 30, 2018 CI
Esperite Resumes Takeover Talks With Polski Bank Komorek Business CI
Esperite NV Introduces Jouvene - Swiss Medicine Quintessence, the First Combined Offer of Stem Cell Long Term Storage and Highly Accurate Whle Genome Sequencing for Consumer Distribution CI
Polski Bank Komórek Macierzystych S.A. cancelled the acquisition of Cryo-Save Family Stem Cell Banking business from Esperite N.V.. CI
Polski Bank Komórek Macierzystych S.A. entered into a memorandum of understanding to acquire Cryo-Save Family Stem Cell Banking business from Esperite N.V. for €10 million. CI
The Cell-Factory BVBA announced that it expects to receive funding from Esperite N.V. CI
Esperite N.V. Reports Consolidated Earnings Results for the Year Ended December 31, 2017 CI
Go Life Healthcare Limited cancelled the acquisition of Cryo-Save South Africa Ltd., from Esperite N.V.. CI
Esperite N.V. with Cryosave Stores More Than A Million Samples in its New Designed Cryostorage Facility in Geneva CI
Go Life Healthcare Limited agreed to acquire Cryo-Save South Africa Ltd., from Esperite N.V. for ZAR 20 million. CI
Esperite N.V. announced that it expects to receive €5 million in funding from L1 Capital Pty Limited CI
Esperite N.V. Launches New AGAATA Diagnostic System with Machine Learning Capabilities for Genetic Clinical Laboratories CI
Esperite N.V. acquired the remaining 50% stake in CryoSave South Africa Ltd from Ecsponent Limited. CI
More news
  1. Stock
  2. Equities
  3. Stock Esperite N.V. - Euronext Amsterdam